Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roper Technologies (ROP) Cash & Equivalents (2016 - 2025)

Roper Technologies' Cash & Equivalents history spans 17 years, with the latest figure at $41.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 78.21% year-over-year to $41.0 million; the TTM value through Dec 2025 reached $41.0 million, down 78.21%, while the annual FY2025 figure was $41.0 million, 78.21% down from the prior year.
  • Cash & Equivalents reached $41.0 million in Q4 2025 per ROP's latest filing, down from $320.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $3.2 billion in Q1 2022 to a low of $41.0 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $782.5 million, with a median of $331.0 million recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: soared 878.1% in 2022, then tumbled 84.19% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $352.5 million in 2021, then surged by 124.91% to $792.8 million in 2022, then plummeted by 72.97% to $214.3 million in 2023, then fell by 12.18% to $188.2 million in 2024, then tumbled by 78.21% to $41.0 million in 2025.
  • Per Business Quant, the three most recent readings for ROP's Cash & Equivalents are $41.0 million (Q4 2025), $320.0 million (Q3 2025), and $242.4 million (Q2 2025).